Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
CEO: |
Sara Barrington |
Non-Executive Director: |
Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough |
Non-Executive Chairman: |
Julian Baines |
Senior Independent Non-Executive Director: |
Ian James Carruthers |
Address: |
Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom |
Phone: |
+44 (0)29 2071 0570 |
Fax: |
|
Website: |
http://www.vericidx.com/ |
Email: |
|